Schizophrenia: all 3,539 studies

Page 13 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.

• A Double-Blind Placebo Controlled Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Negative Symptoms in SchizophreniaCompletedNCT00168311Not applicableResults posted
• Determining Metabolic Effects of Valproate and Antipsychotic TherapyCompletedNCT00167934Not applicableResults posted
• Decreasing Risk of Coronary Artery Disease in Schizophrenia by Omega-3 Fatty Acid SupplementationCompletedNCT00167310Phase 2Results posted
• Effectiveness of Pimozide in Augmenting the Effects of Clozapine in the Treatment of SchizophreniaCompletedNCT00158223Phase 4Results posted
• Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use DisorderCompletedNCT00156715Phase 4Results posted
• Long-Term Efficacy and Safety of Asenapine Using Haloperidol as a Positive Control (41513)(COMPLETED)(P05785)CompletedNCT00156065Phase 3Results posted
• To Determine Long Term Efficacy and Safety of Asenapine in Schizophrenic Patient Population (A7501012)(COMPLETED)(P05770)CompletedNCT00150176Phase 3Results posted
• Addition of Ondansetron to Ongoing Antipsychotic Treatment for SchizophreniaCompletedNCT00149734Phase 3Results posted
• Efficacy and Safety of Asenapine Compared With Olanzapine in Patients With Persistent Negative Symptoms of Schizophrenia (A7501013)(COMPLETED)(P05771)CompletedNCT00145496Phase 3Results posted
• Patient-Centered Medication Adherence Intervention for SchizophreniaCompletedNCT00144027Not applicableResults posted
• Extension Study: Evaluating the Safety of Oral Ziprasidone in the Treatment of Subjects With SchizophreniaCompletedNCT00139737Phase 3Results posted
• Implementing Effective, Collaborative Care for Schizophrenia (EQUIP-2)CompletedNCT00137280Not applicableResults posted
• A Brief Community Linkage Intervention for Dually Diagnosed IndividualsCompletedNCT00137267Not applicableResults posted
• Contingent Incentives Plus Bupropion for Smoking in People With SchizophreniaCompletedNCT00136760Phase 2Results posted
• Long-Acting Injectable Risperidone in the Treatment of SchizophreniaCompletedNCT00132314Phase 3Results posted
• Risperidone Long-acting Versus Oral Risperidone in Patients With Schizophrenia and Alcohol Use DisorderCompletedNCT00130923Phase 4Results posted
• Gamma-Amino Butyric Acid (GABA)-A Alpha2/3 StudyCompletedNCT00129441Phase 2Results posted
• Genetic Research in Schizophrenia Using DNA Markers and Clinical PhenotypesCompletedNCT00108303Results posted
• Aripiprazole Open-Label, Safety and Tolerability StudyCompletedNCT00102518Phase 3Results posted
• Aripiprazole Pharmacokinetics (PK) and Tolerability Study in Children and AdolescentsCompletedNCT00102479Phase 1Results posted
• Aripiprazole in Adolescents With SchizophreniaCompletedNCT00102063Phase 3Results posted
• Phase 2 Trial of a Nicotinic Agonist in SchizophreniaCompletedNCT00100165Phase 2Results posted
• A Study to Test the Effectiveness and Safety of a New Medication in the Treatment of SchizophreniaCompletedNCT00088634Phase 2Results posted
• A Study to Test the Safety and Tolerability of a New Medication in the Treatment of SchizophreniaCompletedNCT00088621Phase 2Results posted
• Open-Label Study of Intramuscular Olanzapine Depot in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT00088465Phase 3Results posted
• Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking ClozapineCompletedNCT00056498Phase 4Results posted
• Treatment of Early Onset Schizophrenia Spectrum Disorders (TEOSS)CompletedNCT00053703Phase 4Results posted
• Switching Medication to Treat SchizophreniaCompletedNCT00044655Phase 4Results posted
• Clinical Trial of Tolcapone for Cognition in SchizophreniaTerminatedNCT00044083Phase 2Results posted
• A Comparison of Study Drug With Placebo and Haloperidol in Patients With SchizophreniaCompletedNCT00044044Phase 2Results posted
• Safety and Tolerability Study of Drug to Treat SchizophreniaCompletedNCT00044005Phase 2Results posted
• Electroconvulsive Therapy in Clozapine Refractory SchizophreniaCompletedNCT00042224Phase 1/2Results posted
• Repetitive Transcranial Magnetic Stimulation for "Voices"CompletedNCT00004980Phase 2Results posted
• Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic DisordersCompletedNCT00001656Phase 4Results posted
• Trial of D-Cycloserine in SchizophreniaCompletedNCT00000371Phase 3Results posted
• Validation and Comparative Multi-Omics Benchmarking of Fluid-Derived Volatilomics Biomarkers for the Prevention and Early Detection of SchizophreniaActive, not recruitingNCT07876089
• Dysfunction of Respiratory Enzymes in Adults With Mental Illness (DREAM)CompletedNCT07866833Not applicable
• A Clinical Trial to Compare the Efficacy and Safety of WAS123 Versus Daily Aripiprazole in the Maintenance Treatment of Patients With Schizophrenia.CompletedNCT07843056Phase 2
• Long-Term Real-World Safety of Cobenfy in Adults With SchizophreniaActive, not recruitingNCT07783373
• Aerobic, Resistance and Inspiratory Muscle Training in Adults With Severe Mental DisorderCompletedNCT07758049Not applicable
• Simulation-Based Schizophrenia Training in Nursing EducationCompletedNCT07757750Not applicable
• A Pilot Study of Adjunctive Structured Supportive Psychotherapy in SchizophreniaCompletedNCT07671040Not applicable
• Effects of ACT-Based Psychoeducation on Caregivers of Individuals With Mental DisordersCompletedNCT07643714Not applicable
• A Computational Neuroscience Perspective on the Shared Social Cognitive Deficits of Autism and SchizophreniaActive, not recruitingNCT07618767
• Virtual Reality-Based Smoking Cessation Treatment in Patients With SchizophreniaCompletedNCT07618338Not applicable
• Cognitive Behavioral Therapy Added to Risperidone for SchizophreniaCompletedNCT07609953Not applicable
• Research Sense of Familiarity in Psychotic PatientsCompletedNCT07608250
• Rochester Forensic Assertive Community Treatment Model in MinnesotaCompletedNCT07592884Not applicable
• Effectiveness of Ashwagandha in Schizophrenia Patients on RisperidoneCompletedNCT07575516Phase 2
• Real-world Patient Characteristics, Treatment Patterns, and Healthcare Utilization Among KarXT UsersCompletedNCT07571148
• A Study Assessing the Efficacy and Safety of HS-10380 in Hospitalized Adults With Acute SchizophreniaCompletedNCT07550387Phase 2
• A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive EpisodeCompletedNCT07549581Phase 1
• Effect of Cognitive Behavioral Therapy on Auditory Hallucinations and NLR in Schizophrenia PatientsCompletedNCT07524868Not applicable
• Effect of Curcumin Add-On Therapy on Quality of Life and IL-1β Levels in Patients With SchizophreniaCompletedNCT07523256Not applicable
• Acceptability and Efficacy of Group Reminiscence Intervention in a Sample of Patients With SchizophreniaCompletedNCT07512843Not applicable
• Supportive Psychotherapy as Adjunct to Risperidone for Cognitive Function and Inflammation in SchizophreniaCompletedNCT07477301Phase 2
• Transcranial Direct Current Stimulation (tDCS) in Different Psychiatric DisordersCompletedNCT07452835Not applicable
• TIS for Improving Cognitive Impairment Associated With SchizophreniaCompletedNCT07446478Not applicable
• Predictive Validity of the Personal and Social Performance Scale for PANSS Outcomes in SchizophreniaCompletedNCT07445217Phase 2
• Theta- and Alpha-Tuned Meditation for Negative Symptoms in SchizophreniaCompletedNCT07437365Not applicable
• LRFN5 and OLFM4 in SchizophreniaCompletedNCT07434388
• Clay Therapy in Schizophrenia PatientsCompletedNCT07378150Not applicable
• Impact of Medication Education on Adherence and Side EffectsCompletedNCT07374588Not applicable
• Efficacy of Pediococcus Acidilactici as add-on to Antipsychotic Drugs on Metabolic Syndrome Disturbances in First-episode Psychosis and Schizophrenia Spectrum Disorders.CompletedNCT07371325Not applicable
• Effect of Psychoeducation -Based Motivational Interviewing on Knowledge and Hope in SchizophreniaCompletedNCT07365982Not applicable
• Berberine Improving Cognitive Impairments in SchizophreniaCompletedNCT07359209Not applicable
• Cinematic Virtual Reality Intervention for Improving Psychosocial Functioning in Individuals With SchizophreniaCompletedNCT07326618Not applicable
• Mindfulness Psychoeducation for SchizophreniaCompletedNCT07310615Not applicable
• A Trial to Test the Effects of Other Drugs on SEP-380135 in Healthy Men and WomenCompletedNCT07305779Phase 1
• A Food Effect Study of LY03020 in Healthy SubjectsActive, not recruitingNCT07292233Phase 1
• Bioequivalence Study of Long-Acting Paliperidone Palmitate in Patients With SchizophreniaCompletedNCT07268430Not applicable
• Bioequivalence Study to Compare Brexpiprazole 4 mg Film Coated Tablets Versus RXULTI 4 mg Film Coated Tablet (Brexpiprazole)CompletedNCT07266792Phase 1
• A Study to Evaluate KYN-5356 in Adults With Cognitive Impairment Associated With SchizophreniaCompletedNCT07191483Phase 2
• Comparison of the Effects of Physical Activity and Virtual Reality Training in Patients With SchizophreniaCompletedNCT07173465Not applicable
• Effects of an Interpersonal Communication Skills Training Program on Medication Adherence of Schizophrenic PatientsCompletedNCT07165821Not applicable
• Accelerated DMN-Targeted cTBS to Modulate DMN ConnectivityCompletedNCT07155096Not applicable
• Video Game-facilitated Group Activity for Quality of Life and Social Function in Chronic Schizophrenia Inpatients.Active, not recruitingNCT07148609Not applicable
• Assessment of Physical Activity, Balance, Muscle Strength, and Cognitive Function in Patients Diagnosed With SchizophreniaCompletedNCT07141966
• Physical Fitness, Physical Activity Level, Depression and Quality of Life in Bipolar and Schizophrenia PatientsCompletedNCT07140042
• Arts-based Social Prescribing for Mental HealthCompletedNCT07137572Not applicable
• MBRS-Based Psychoeducation in Patients With SchizophreniaCompletedNCT07130227Not applicable
• Bioequivalence Assessment Between Two Cariprazine Hard Capsule FormulationsCompletedNCT07121868Phase 1
• Adjunctive iTBS for First-Episode SchizophreniaCompletedNCT07116850Not applicable
• Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar DisorderCompletedNCT07116694Phase 2
• The Effect of Virtual Reality on Cognitive Skills in SchizophreniaCompletedNCT07111689Not applicable
• Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode SchizophreniaCompletedNCT07102069
• Obsessive-Compulsive Disorder: Insight, Trauma, and Links to Schizophrenia Spectrum DisordersActive, not recruitingNCT07092826
• Recovery in Telling Life StoriesActive, not recruitingNCT07082777Not applicable
• Mindfulness-Based Education for Caregivers of Individuals Diagnosis With SchizophreniaCompletedNCT07076940Not applicable
• Contribution of Virtual Reality Eye Tracking in the Identification of Schizophrenia, Bipolar and DepressionActive, not recruitingNCT07057024Not applicable
• Effectiveness of Traditional Chinese Metacognitive Training (MCT) in Patients With Schizophrenia, Depression, or Bipolar Disorder Attending a Psychiatric Day Hospital in TaiwanCompletedNCT07051746Not applicable
• Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric DisordersCompletedNCT07043803Not applicable
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Inpatient Adults With SchizophreniaCompletedNCT07038876Phase 2
• Investigation of the Effects of Virtual Reality Applications on Individuals Diagnosed With SchizophreniaActive, not recruitingNCT07027085Not applicable
• The Effectiveness of Psychosocial Skills Training Applied to Individuals Diagnosed With SchizophreniaCompletedNCT07017881Not applicable
• Cultural Adaptation of Group CBT Psychosis Manual and Establishing Its Efficacy in PakistanCompletedNCT07005388Not applicable
• Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental DisordersCompletedNCT07005245
• ENGAGE: Virtual Reality-based Psychotherapy for Negative Symptoms in SchizophreniaCompletedNCT06993831Not applicable
• The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.CompletedNCT06993662Phase 1
• Efficacy & Tolerability of Rigth Unilateral vs. Bitemporal ECT in Schizophrenia in a Psychiatric Hospital in MexicoTerminatedNCT06972745Not applicable

← Schizophrenia overview